Daniel Dolan

Insider Reports History

Location
King Of Prussia, PA
Signature
/s/ J. Christopher Naftzger, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daniel Dolan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Nabriva Therapeutics plc Chief Financial Officer Stock Appreciation Right 83.2K 11 Aug 2022 Direct
Nabriva Therapeutics plc Chief Financial Officer Phantom Shares 41.6K 11 Aug 2022 Direct
Nabriva Therapeutics plc Chief Financial Officer Restricted Stock Units 0 11 Aug 2022 Direct
Nabriva Therapeutics plc Chief Financial Officer Share Options 0 11 Aug 2022 Direct

Insider Reports Filed by Daniel Dolan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NBRV Nabriva Therapeutics plc 11 Aug 2022 4 $0 4 Chief Financial Officer 15 Aug 2022, 20:39
NBRV Nabriva Therapeutics plc 28 Jan 2022 2 $0 4 Chief Financial Officer 01 Feb 2022, 17:39